Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach
Open Access
- 12 October 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (20) , 6489
Abstract
Metabolic Associated Fatty Liver Disease (MASLD) is a condition that is often present in patients with a history of cholecystectomy. This is because both situations share interconnected metabolic pathways. This study aimed to establish a predictive model that allows for the identification of patients at risk of developing hepatic fibrosis following this surgery, with potential implications for surgical decision-making. A retrospective cross-sectional analysis was conducted in four hospitals using a database of 211 patients with MASLD who underwent cholecystectomy. MASLD diagnosis was established through liver biopsy or FibroScan, and non-invasive test scores were included for analysis. Various Machine Learning (ML) methods were employed, with the Adaptive Boosting (Adaboost) system selected to build the predictive model. Platelet level emerged as the most crucial variable in the predictive model, followed by dyslipidemia and type-2 diabetes mellitus. FIB-4 score proved to be the most reliable non-invasive test. The Adaboost algorithm improved the results compared to the other methods, excelling in both accuracy and area under the curve (AUC). Moreover, this system holds promise for implementation in hospitals as a valuable diagnostic support tool. In conclusion, platelet level (<150,000/dL), dyslipidemia, and type-2 diabetes mellitus were identified as primary risk factors for liver fibrosis in MASLD patients following cholecystectomy. FIB-4 score is recommended for decision-making, particularly when the indication for surgery is uncertain. This predictive model offers valuable insights into risk stratification and personalized patient management in post-cholecystectomy MASLD cases.Keywords
Funding Information
- Fundación Investigación Hospital General Universitario de Valencia
This publication has 59 references indexed in Scilit:
- The increasing incidence of gallbladder disease in children: A 20year perspectiveJournal of Pediatric Surgery, 2016
- Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta‐analysisWorld Journal of Surgery, 2016
- Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsyHepatology, 2016
- Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic SteatosisWorld Journal of Surgery, 2016
- Exploitation of Cholane Scaffold for the Discovery of Potent and Selective Farnesoid X Receptor (FXR) and G-Protein Coupled Bile Acid Receptor 1 (GP-BAR1) LigandsJournal of Medicinal Chemistry, 2014
- Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapyNature Reviews Gastroenterology & Hepatology, 2014
- Association of Cholecystectomy with Metabolic Syndrome in a Chinese PopulationPLOS ONE, 2014
- Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in miceHepatology, 2012
- Pregnane X Receptor Is a Target of Farnesoid X ReceptorJournal of Biological Chemistry, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005